This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 6 Stocks in 60 Seconds: DIS PFE AAPL SBUX TTWO FURX (Update 1)

Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".

(Updates from 11:10 a.m. ET with closing information and corrects ticker symbol in headline.)

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Tuesday.

Merrill Lynch/Bank of America placed Disney (DIS - Get Report) on its buy list. The company reports earnings on Wednesday. Cramer thinks the analyst is positioning to buy shares in case of a decline. "I like this call," he said. DIS rose 1.5% to close at $71.05.

Jefferies upgraded Pfizer (PFE - Get Report) to buy from hold and raised its price target to $38 from $33. The company is beginning to get some love from the analysts over its strengthening oncology pipeline, much like what happened to Bristol-Myers Squibb (BMY), Cramer said. "This is good news," Cramer concluded. PFE was 2.8% higher at $31.44.

Cramer agreed with Morgan Stanley that "wearables are going to be gigantic," referring to Apple's (AAPL - Get Report) expected product launches this year. He said Apple has become a defensive play in the current market because it has held up relatively well compared to the broader market. AAPL is a holding in Cramer's charitable trust, Action Alerts PLUS. AAPL rose 1.5% to $508.79.

Deutsche Bank says not to worry about rising coffee prices hurting Starbucks (SBUX - Get Report). Cramer said the stock "doesn't deserve" to be trading at $68, which is where it closed on Monday. SBUX perked up 2.4% to $70.65.

Despite beating on the top and bottom lines and having nearly half of its market cap comprised of cash, shares of Take-Two Interactive Software (TTWO - Get Report) are plunging in Tuesday's trading session. "Everybody hates it," Cramer said, because management didn't guide aggressively for next quarter. TTWO dropped 9.7% to $17.06.

Furiex Pharmaceuticals (FURX) "is a little too speculative for me," Cramer said. The company met the goals of two Phase III trials for its irritable bowel syndrome drug. As a result, shares have more than doubled. FURX vaulted 129.9% to $105.69.

To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.

-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had a position in AAPL.

  Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

  None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

  Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FURX $0.00 0.00%
AAPL $124.75 0.00%
DIS $106.69 0.00%
PFE $35.04 0.00%
SBUX $47.62 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs